Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mallory

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Journal of Medical Virology|October 21, 2025
Detection of Anti-SARS-CoV-2 Mucosal Immunoglobulin A in Clinical Saliva Samples After a Dose of Novavax COVID-19 VaccineMingzhu Zhu, Edmond Massuda, Urvashi Patel, et al.
Vaccine|December 27, 2025
Safety and immunogenicity of a single dose of a JN.1 variant COVID-19 vaccine in previously vaccinated adults: Primary analysis report of a phase 3 open-label trialKatia Alves, Alex Kouassi, Joy Nelson, et al.
Vaccine|April 4, 2025
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label studyKatia Alves, Alex Kouassi, Joyce S Plested, et al.
Annals of Neurology|December 24, 1997
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research CenterE Masliah, R K Heaton, T D Marcotte, et al.
The Journal of Allergy and Clinical Immunology|March 28, 2025
Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine dosesJeffrey M Adelglass, Paul Bradley, Miranda R Cai, et al.
The Pediatric Infectious Disease Journal|May 1, 2010
Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirusElaine L Duryea, Pablo J Sánchez, Jeanne S Sheffield, et al.
Human Vaccines & Immunotherapeutics|July 2, 2026
Safety and immunogenicity of a COVID-19-Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trialVivek Shinde, Wayne Woo, Anthony M Marchese, et al.
The Journal of Infectious Diseases|May 21, 2023
Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary VaccinationLouis Fries, Neil Formica, Raburn M Mallory, et al.
Annals of Surgical Oncology|December 18, 2025
ASO Visual Abstract: Post-operative Impact of Closed Incision Negative Pressure Therapy Following Oncoplastic Breast SurgeryN Harris, P Aiello, D Detz, et al.
Annals of Surgical Oncology|November 15, 2025
Postoperative Impact of Closed Incision Negative Pressure Therapy Following Oncoplastic Breast SurgeryN Harris, P Aiello, D Detz, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Journal of Medical Virology|October 21, 2025
Detection of Anti-SARS-CoV-2 Mucosal Immunoglobulin A in Clinical Saliva Samples After a Dose of Novavax COVID-19 VaccineMingzhu Zhu, Edmond Massuda, Urvashi Patel, et al.
Vaccine|December 27, 2025
Safety and immunogenicity of a single dose of a JN.1 variant COVID-19 vaccine in previously vaccinated adults: Primary analysis report of a phase 3 open-label trialKatia Alves, Alex Kouassi, Joy Nelson, et al.
Vaccine|April 4, 2025
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label studyKatia Alves, Alex Kouassi, Joyce S Plested, et al.
Annals of Neurology|December 24, 1997
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research CenterE Masliah, R K Heaton, T D Marcotte, et al.
The Journal of Allergy and Clinical Immunology|March 28, 2025
Immunogenicity of adjuvanted recombinant SARS-CoV-2 spike protein vaccine after earlier mRNA vaccine dosesJeffrey M Adelglass, Paul Bradley, Miranda R Cai, et al.
The Pediatric Infectious Disease Journal|May 1, 2010
Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirusElaine L Duryea, Pablo J Sánchez, Jeanne S Sheffield, et al.
Human Vaccines & Immunotherapeutics|July 2, 2026
Safety and immunogenicity of a COVID-19-Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trialVivek Shinde, Wayne Woo, Anthony M Marchese, et al.
The Journal of Infectious Diseases|May 21, 2023
Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary VaccinationLouis Fries, Neil Formica, Raburn M Mallory, et al.
Annals of Surgical Oncology|December 18, 2025
ASO Visual Abstract: Post-operative Impact of Closed Incision Negative Pressure Therapy Following Oncoplastic Breast SurgeryN Harris, P Aiello, D Detz, et al.
Annals of Surgical Oncology|November 15, 2025
Postoperative Impact of Closed Incision Negative Pressure Therapy Following Oncoplastic Breast SurgeryN Harris, P Aiello, D Detz, et al.
Pageof 16